{"id":"W4389227554","doi":"10.1158/1535-7163.targ-23-b154","title":"Abstract B154: Safety and preliminary activity of the selective ALK inhibitor NVL-655 in patients with ALK fusion-positive solid tumors","year":2023,"lang":"en","type":"article","venue":"Molecular Cancer Therapeutics","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Anaplastic lymphoma kinase; Tolerability; ALK inhibitor; Crizotinib; Response Evaluation Criteria in Solid Tumors; Adverse effect; Internal medicine; Pharmacodynamics; Lung cancer; Refractory (planetary science); Pharmacokinetics; Oncology; Pharmacology; Clinical trial; Phases of clinical research","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005967066,0.0004253222,0.0006253258,0.0001908348,0.0002424403,0.0005725676,0.0002523363,0.000418273,0.002318981],"category_scores_gemma":[0.0005580221,0.0001625554,0.0004692186,0.0001817445,0.0002118793,0.0003519922,0.0001610271,0.001168481,0.0006501566],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005941239,"about_ca_system_score_gemma":0.0006762065,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0008448891,"about_ca_topic_score_gemma":0.001550475,"domain_scores_codex":[0.9998178,0.00006755807,0.00002082876,0.00003259479,0.00002991092,0.00003131542],"domain_scores_gemma":[0.9997374,0.00004260151,0.00005903576,0.00001894684,0.00002531712,0.0001168001],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.2544563,0.02677739,0.04804307,0.001475827,0.001286722,0.001475472,0.0004610012,0.004046863,0.1722307,0.0004867543,0.01388502,0.4753749],"study_design_scores_gemma":[0.09395256,0.6790349,0.1476328,0.0002475869,0.001165144,0.003293291,0.0002433193,0.005234599,0.04369268,0.0003878461,0.02504618,0.00006916164],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9914409,0.003385045,0.0005620827,0.0002899887,0.00006403579,0.0002894982,0.0009708242,0.0001291465,0.002868423],"genre_scores_gemma":[0.9966261,0.0005845264,0.0003115765,0.0002723526,0.00003856359,0.00008253829,0.001059312,0.00000992755,0.001014962],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002318981,"threshold_uncertainty_score":0.007757783,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.008498528870247834,"score_gpt":0.2872503505718201,"score_spread":0.2787518217015723,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}